Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple‐negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta
Authors:
Open Access
- 28 January 2022
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (1) , e725
Abstract
Triple‐negative breast cancer (TNBC) is fast‐growing and highly metastatic with the poorest prognosis among the breast cancer subtypes. Inactivation of glycogen synthase kinase 3 beta (GSK3β) plays a vital role in the aggressiveness of TNBC; however, the underlying mechanism for sustained GSK3β inhibition remains largely unknown. Here, we find that protein phosphatase 1 regulatory inhibitor subunit 14C (PPP1R14C) is upregulated in TNBC and relevant to poor prognosis in patients. Overexpression of PPP1R14C facilitates cell proliferation and the aggressive phenotype of TNBC cells, whereas the depletion of PPP1R14C elicits opposite effects. Moreover, PPP1R14C is phosphorylated and activated by protein kinase C iota (PRKCI) at Thr73. p‐PPP1R14C then represses Ser/Thr protein phosphatase type 1 (PP1) to retain GSK3β phosphorylation at high levels. Furthermore, p‐PPP1R14C recruits E3 ligase, TRIM25, toward the ubiquitylation and degradation of non‐phosphorylated GSK3β. Importantly, the blockade of PPP1R14C phosphorylation inhibits xenograft tumorigenesis and lung metastasis of TNBC cells. These findings provide a novel mechanism for sustained GSK3β inactivation in TNBC and suggest that PPP1R14C might be a potential therapeutic target.Keywords
All Related Versions
Funding Information
- National Key Research and Development Program of China (2020YFA0509400)
- National Natural Science Foundation of China (82003052, 82003128, 81802405)
- Natural Science Foundation of Guangdong Province (2020A1515010260)
This publication has 55 references indexed in Scilit:
- Small Molecules Targeted to a Non-Catalytic “RVxF” Binding Site of Protein Phosphatase-1 Inhibit HIV-1PLOS ONE, 2012
- GSK-3: A Bifunctional Role in Cell Death PathwaysInternational Journal of Cell Biology, 2012
- DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cellsJournal of Clinical Investigation, 2012
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Protein phosphatases 1 and 2A are both required for long‐term depression and associated dephosphorylation of cAMP response element binding protein in hippocampal area CA1 in vivoHippocampus, 2010
- GSK3 signalling in neural developmentNature Reviews Neuroscience, 2010
- Dehydroepiandrosterone Reverses Systemic Vascular Remodeling Through the Inhibition of the Akt/GSK3-β/NFAT AxisCirculation, 2009
- Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cellsCell Research, 2006
- KEPI, a PKC-dependent Protein Phosphatase 1 Inhibitor Regulated by MorphineJournal of Biological Chemistry, 2002
- Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1The EMBO Journal, 1997